AMD and Validation Rod-Meditated Dark Adaptation With Everyday Task Performance

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-89
SponsorDuke University

About this trial

The goal is to conduct a cross-sectional, single timepoint study on older adults with early and intermediate AMD, and with subretinal drusenoid deposits (SDD), and those in normal health, establishing an association between dark adaptation and reading performance under dim illumination, both which depend on rod photoreceptors.

Eligibility criteria

Qualifiers

Capable and willing to provide consent

Has been diagnosed with early, intermediate dry age-related macular degeneration or geographic atrophy or has a healthy macular for controls

At least 50 years of age

Disqualifiers

Unable or unwilling to give consent or unable to read consent since the study involves testing which requires reading

Under 50 years of age

Presence of dense cataracts in the study eye (s) that can affect visual function tests

Presence of glaucoma requiring treatment during the study and/or visual field defects

Trial design

Treatments tested in this trial

  • Streetlab VR

Treatment groups

100 Participants
are divided into 4 treatment groups

Sponsors and collaborators

Duke University

Lead sponsor

Boehringer Ingelheim

Collaborator

StreetLab Vision

Collaborator